NFKB1 and myocardial infarction: The NF-κB signaling pathway, which was widely known as a classical pathway involved in inflammatory and fibrotic responses during various diseases, was recently demonstrated promoting adverse cardiac remodeling post-myocardial infarction by aggravating and prolonging the inflammatory and fibrotic processes (Martinez-Martinez et al., 2017; Wang B. et al., 2017).